kidney disease

The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.

UK researchers are launching a clinical trial to investigate if the drug niclosamide, usually used to treat tapeworms, can prevent COVID-19 infection in vulnerable, high risk kidney patients and reduce the number of people who become seriously ill or die from it.